Our vision is to set up a sustainable and flexible platform for molecular imaging of immune cell dynamics using novel tracer strategies. New immunotracers will enable smart monitoring of immunotherapies and widespread usage of a personalized medicine approach.
Patient Input Wanted: Designing Immune-Image Panel for Cancer/Inflammatory Diseases
We have developed a questionnaire to better understand the added value and expectations from patients, patient advocates and caregivers regarding their involvement and engagement in Immune-Image, a European research project on immunotherapy. By participating in this survey, you will help with the design and setup of a patient panel for our project.
the Immune-Image newsletter!
Don’t you want to miss any information about the project like interviews with researchers, the latest news or events? Sign up for our newsletter! The newsletter is sent quarterly.
Immunotherapies are revolutionising the treatment of many cancers and inflammatory diseases. However, immunotherapies are not always successful due to specific disease features in each patient and adaption of the immune system and the tumor during treatment. Therefore, there is an urgent clinical need to assess the immune status of individual patient and to regularly monitor the response to immunotherapy.
Immune-Image will develop methods to visualize and study the immune cells involved before, during, and after immunotherapy, allowing selection of the right treatment for the right patient at the right time.
Immune-Image brings together 22 key stakeholders from across 9 countries. This consortium comprises 10 academic institutions, 4 SMEs, 1 patient organization and 7 pharmaceutical companies.
The immune system is our body's natural defense mechanism against diseases, including cancer. It has evolved to recognize and eliminate abnormal cells before they can cause harm. However, cancer cells often find ways to evade the immune system's attacks, allowing them...
The Immune-Image project aims to develop and implement a novel non-invasive molecular imaging platform for assessing immune cell activation and dynamics in oncology and inflammatory diseases, both in animal models and in patients. If you would like to read more about...